Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Depression (Major/Severe)
Location: United States, IL
Clinical Trial Details
Research Study Summary
A multicenter, randomized, double-blind study to evaluate the efficacy, safety and tolerability of an oral Aripiprazole-Escitalopram combination therapy in patients with Major Depressive Disorder.
This study is being done to find out the potential benefits and safety of taking two different study drugs at the same time. The study drugs are called Abilify(aripiprazole) and Lexapro(Escitalopram).
Please contact Alexian Brothers for more information on participation.
To Learn more
Both Male and Female
Date Last Changed:
July 22, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.